End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.92 USD | -2.79% | +0.69% | +110.77% |
05-16 | HC Wainwright Initiates Dianthus Therapeutics With Buy Rating, $40 Price Target | MT |
05-10 | Wedbush Adjusts Dianthus Therapeutics' Price Target to $38 From $33, Keeps Outperform Rating | MT |
Chart: Technical Analysis
- Stock Market
- Equities
- DNTH Stock
- Charts Dianthus Therapeutics, Inc.